Web Exclusives

A modular content strategy is rapidly emerging as the best practice for developing, reusing and delivering compliant digital content at scale with speed

How does prioritising the customer lead to a more successful launch?

Dr Daniel Streetman considers whether immunosuppressants can reduce the response to COVID-19 vaccines

Three ways technology can support NHS workers today, tomorrow and into the future

How start-ups can bridge the gap and grow with venture capital support

Four ways pharma must embrace tech to weather the COVID storm

New science shines a bright light on the future of UK biopharma

Clinical trials must deal with extreme amounts of diverse data which are generated across several institutions. A flexible data architecture can help shorten the journey to approval and distribution

Professor Saad Shakir on the gap in public knowledge about routine drug safety and pharmacovigilance activity

Delivering internal and external diversity in pharma

Jeff Elton, chief executive of ConcertAI, talks to PharmaTimes about the pandemic’s impact on oncology trials in the US

How pharma can use natural language processing for drug safety predictions

Optimising value propositions for payers – some simple rules

A theme of the decade that health chief marketing officer’s can’t afford to ignore